Yorkshire and Humber's annual HIV surveillance reveals testing disparities and diagnostic gaps across the region, alongside strong treatment outcome…
#Antiretroviraltherapy #Healthequity #HIVsurveillance #Publichealth #Regionalepidemiology
#Antiretroviraltherapy #Healthequity #HIVsurveillance #…
#Antiretroviraltherapy #Healthequity #HIVsurveillance #Publichealth #Regionalepidemiology
#Antiretroviraltherapy #Healthequity #HIVsurveillance #…
HIV Yorkshire & Humber: Annual epidemiological data reveals testing gaps
Yorkshire and Humber's annual HIV surveillance reveals testing disparities and diagnostic gaps across the region, alongside strong treatment outcome…
#Antiretroviraltherapy #Healthequity #HIVsurveillance #Publichealth #Regionalepidemiology
news.gmj.ge
October 3, 2026 at 3:26 AM
Yorkshire and Humber's annual HIV surveillance reveals testing disparities and diagnostic gaps across the region, alongside strong treatment outcome…
#Antiretroviraltherapy #Healthequity #HIVsurveillance #Publichealth #Regionalepidemiology
#Antiretroviraltherapy #Healthequity #HIVsurveillance #…
#Antiretroviraltherapy #Healthequity #HIVsurveillance #Publichealth #Regionalepidemiology
#Antiretroviraltherapy #Healthequity #HIVsurveillance #…
A new BMJ Global Health study finds 2.7 million Malians cannot access antiretroviral therapy within 2 hours' travel time. Geographic distance bloc…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
#Antiretroviraltherapy #Geographicaccessibility #Heal…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
#Antiretroviraltherapy #Geographicaccessibility #Heal…
2.7 Million Malians Blocked From HIV Treatment
A new BMJ Global Health study finds 2.7 million Malians cannot access antiretroviral therapy within 2 hours' travel time. Geographic distance bloc…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
news.gmj.ge
September 21, 2026 at 1:27 AM
A new BMJ Global Health study finds 2.7 million Malians cannot access antiretroviral therapy within 2 hours' travel time. Geographic distance bloc…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
#Antiretroviraltherapy #Geographicaccessibility #Heal…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
#Antiretroviraltherapy #Geographicaccessibility #Heal…
Early metabolic risk evaluation and preventive measures at #AntiretroviralTherapy initiation are critical for managing age-related comorbidities in people with #HIV.
Obesity at ART Initiation May Increase Long-Term Clinical Risk in HIV
Baseline obesity in adults initiating ART may worsen long-term comorbidity and mortality risks, particularly in younger patients.
www.infectiousdiseaseadvisor.com
September 16, 2026 at 7:11 PM
Early metabolic risk evaluation and preventive measures at #AntiretroviralTherapy initiation are critical for managing age-related comorbidities in people with #HIV.
📈 Among children living with #HIV in 13 sub-Saharan African countries, maternal HIV care engagement was associated with higher child viral suppression primarily through increased #AntiretroviralTherapy uptake. ja.ma/4xb7t1I
Maternal Engagement in HIV Care and ART Uptake Among Children With HIV
This cross-sectional study examines the role of antiretroviral therapy (ART) use and viral load suppression among mothers in their children’s viral load suppression in sub-Saharan Africa.
ja.ma
September 10, 2026 at 1:30 PM
📈 Among children living with #HIV in 13 sub-Saharan African countries, maternal HIV care engagement was associated with higher child viral suppression primarily through increased #AntiretroviralTherapy uptake. ja.ma/4xb7t1I
A new BMJ Global Health study finds 2.7 million Malians cannot access antiretroviral therapy within 2 hours' travel time. Geographic distance bloc…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
#Antiretroviraltherapy #Geographicaccessibility #Heal…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
#Antiretroviraltherapy #Geographicaccessibility #Heal…
2.7 Million Malians Blocked From HIV Treatment
A new BMJ Global Health study finds 2.7 million Malians cannot access antiretroviral therapy within 2 hours' travel time. Geographic distance bloc…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
news.gmj.ge
September 10, 2026 at 4:41 AM
A new BMJ Global Health study finds 2.7 million Malians cannot access antiretroviral therapy within 2 hours' travel time. Geographic distance bloc…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
#Antiretroviraltherapy #Geographicaccessibility #Heal…
#Antiretroviraltherapy #Geographicaccessibility #Healthequity #HIVtreatment #Malihealthsystem
#Antiretroviraltherapy #Geographicaccessibility #Heal…
From @ofidjournal.bsky.social 🦠
A phase 3b trial shows DTG/3TC offers noninferior #ViralSuppression when compared with BIC/FTC/TAF in adults initiating #AntiretroviralTherapy, highlighting the utility of simplified 2-drug regimens for initial #HIV1 treatment across a broad patient population. #IDSky
A phase 3b trial shows DTG/3TC offers noninferior #ViralSuppression when compared with BIC/FTC/TAF in adults initiating #AntiretroviralTherapy, highlighting the utility of simplified 2-drug regimens for initial #HIV1 treatment across a broad patient population. #IDSky
Dolutegravir Plus Lamivudine Matches 3-Drug ART in Treatment-Naive HIV-1
DTG/3TC achieves noninferior virologic suppression when compared with BIC/FTC/TAF in adults initiating first-line ART for HIV-1.
www.infectiousdiseaseadvisor.com
August 21, 2026 at 6:19 PM
From @ofidjournal.bsky.social 🦠
A phase 3b trial shows DTG/3TC offers noninferior #ViralSuppression when compared with BIC/FTC/TAF in adults initiating #AntiretroviralTherapy, highlighting the utility of simplified 2-drug regimens for initial #HIV1 treatment across a broad patient population. #IDSky
A phase 3b trial shows DTG/3TC offers noninferior #ViralSuppression when compared with BIC/FTC/TAF in adults initiating #AntiretroviralTherapy, highlighting the utility of simplified 2-drug regimens for initial #HIV1 treatment across a broad patient population. #IDSky
#pharma #HIV #GileadSciences #MSD #lenacapavir #islatravir #clinicaltrials #infectiousdiseases #Gilead #oralHIVtreatment #HIVtreatment #phase3trials #capsidinhibitor #ISLEND1trial #ISLEND2trial #antiretroviraltherapy #ART #FDA #Sunlenca #MDRHIV #HIVpreexposureprophylaxis #PrEP #NNRTI
zurl.co/gq0wN
zurl.co/gq0wN
Gilead, MSD share data on once-weekly oral HIV treatment
Gilead/MSD's once-weekly oral medicine for HIV has been shown to achieve high rates of viral suppression in phase 3, setting up regulatory filings.
pharmaphorum.com
August 20, 2026 at 7:59 AM
Breaking: NHS emergency department HIV testing has identified 1,953 previously undiagnosed cases over four years across 88 English areas. The opt-out screening p…
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedicine #HIV
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedi…
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedicine #HIV
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedi…
NHS A&E HIV Testing: 1,953 Cases Diagnosed
Breaking: NHS emergency department HIV testing has identified 1,953 previously undiagnosed cases over four years across 88 English areas. The opt-out screening p…
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedicine #HIV
news.gmj.ge
August 10, 2026 at 3:29 PM
Breaking: NHS emergency department HIV testing has identified 1,953 previously undiagnosed cases over four years across 88 English areas. The opt-out screening p…
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedicine #HIV
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedi…
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedicine #HIV
#Antiretroviraltherapy #Casefinding #Diagnosis #Emergencymedi…
During the Tigray War, #HIV diagnoses, linkage to care, and #AntiretroviralTherapy initiation in Mekelle declined substantially compared with prewar trends.
ja.ma/4cfXY9P
ja.ma/4cfXY9P
August 2, 2026 at 5:24 AM
During the Tigray War, #HIV diagnoses, linkage to care, and #AntiretroviralTherapy initiation in Mekelle declined substantially compared with prewar trends.
ja.ma/4cfXY9P
ja.ma/4cfXY9P
From @cidjournal.bsky.social 🦠
Long-acting #AntiretroviralTherapy supports virologic suppression in people with #HIV facing adherence barriers and baseline viremia, highlighting its clinical utility in real-world settings. #IDSky
Long-acting #AntiretroviralTherapy supports virologic suppression in people with #HIV facing adherence barriers and baseline viremia, highlighting its clinical utility in real-world settings. #IDSky
Long-Acting ART Achieves HIV Virologic Suppression in Patients With Viremia
Real-world data demonstrate high rates of viral suppression among PWH with viremia who initiate LA CAB/RPV.
www.infectiousdiseaseadvisor.com
July 31, 2026 at 2:24 PM
From @cidjournal.bsky.social 🦠
Long-acting #AntiretroviralTherapy supports virologic suppression in people with #HIV facing adherence barriers and baseline viremia, highlighting its clinical utility in real-world settings. #IDSky
Long-acting #AntiretroviralTherapy supports virologic suppression in people with #HIV facing adherence barriers and baseline viremia, highlighting its clinical utility in real-world settings. #IDSky
Nearly half of all #children living with #HIV have no access to #antiretroviraltherapy in 2025. This is preventable, treatable — and we're failing them. Budget cuts, criminalisation, inequity. We can do better.
zmina.info/en/news-en/h...
#ActOnHIV #WorldAIDSDay #HIV #AIDS #HIVPrevention
#UNAIDS
zmina.info/en/news-en/h...
#ActOnHIV #WorldAIDSDay #HIV #AIDS #HIVPrevention
#UNAIDS
HIV funding cut by a fifth: UNAIDS warns of epidemic resurgence as 570,000 AIDS deaths recorded in 2025 ➜ ZMINA
HIV funding cut by a fifth: UNAIDS warns of epidemic resurgence as 570,000 AIDS deaths recorded in 2025 UNAIDS estimates that 20 million people need access to antiretroviral-based prevention to have a...
zmina.info
July 28, 2026 at 11:50 AM
Nearly half of all #children living with #HIV have no access to #antiretroviraltherapy in 2025. This is preventable, treatable — and we're failing them. Budget cuts, criminalisation, inequity. We can do better.
zmina.info/en/news-en/h...
#ActOnHIV #WorldAIDSDay #HIV #AIDS #HIVPrevention
#UNAIDS
zmina.info/en/news-en/h...
#ActOnHIV #WorldAIDSDay #HIV #AIDS #HIVPrevention
#UNAIDS
New research explains why some HIV patients have persistent viral traces despite successful treatment. Study finds defective copi…
#Antiretroviraltherapy #Clinicalresearch #HIVtreatment #InfectiousDisease #Viralload
#Antiretroviraltherapy #Clinicalresearch #HIVtreatment #InfectiousDisease #Vira…
#Antiretroviraltherapy #Clinicalresearch #HIVtreatment #InfectiousDisease #Viralload
#Antiretroviraltherapy #Clinicalresearch #HIVtreatment #InfectiousDisease #Vira…
HIV Study Reveals Source of Persistent Viral Traces
New research explains why some HIV patients have persistent viral traces despite successful treatment. Study finds defective copi…
#Antiretroviraltherapy #Clinicalresearch #HIVtreatment #InfectiousDisease #Viralload
news.gmj.ge
July 5, 2026 at 8:43 AM
New research explains why some HIV patients have persistent viral traces despite successful treatment. Study finds defective copi…
#Antiretroviraltherapy #Clinicalresearch #HIVtreatment #InfectiousDisease #Viralload
#Antiretroviraltherapy #Clinicalresearch #HIVtreatment #InfectiousDisease #Vira…
#Antiretroviraltherapy #Clinicalresearch #HIVtreatment #InfectiousDisease #Viralload
#Antiretroviraltherapy #Clinicalresearch #HIVtreatment #InfectiousDisease #Vira…
People with #HIV who have never been on #AntiRetroviralTherapy have a notable prevalence of #CardiometabolicDiseases, indicating a cardiometabolic burden is present prior to ART initiation.
Read more ⬇️
https://www.infectiousdiseaseadvisor.com/news/cardiometabolic-diseases-burden-antiretrovirals-hiv/
Read more ⬇️
https://www.infectiousdiseaseadvisor.com/news/cardiometabolic-diseases-burden-antiretrovirals-hiv/
June 17, 2026 at 9:45 PM
People with #HIV who have never been on #AntiRetroviralTherapy have a notable prevalence of #CardiometabolicDiseases, indicating a cardiometabolic burden is present prior to ART initiation.
Read more ⬇️
https://www.infectiousdiseaseadvisor.com/news/cardiometabolic-diseases-burden-antiretrovirals-hiv/
Read more ⬇️
https://www.infectiousdiseaseadvisor.com/news/cardiometabolic-diseases-burden-antiretrovirals-hiv/
From @ofidjournal.bsky.social 🦠
#Dolutegravir-based #AntiRetroviralTherapy demonstrates superior efficacy compared with standard care regimens over 240 weeks among pediatric patients with #HIV, reinforcing current WHO guidelines.
#Dolutegravir-based #AntiRetroviralTherapy demonstrates superior efficacy compared with standard care regimens over 240 weeks among pediatric patients with #HIV, reinforcing current WHO guidelines.
Dolutegravir Improves Long-Term HIV Outcomes in Children and Adolescents
Among pediatric patients with HIV, DTG-based ART showed superior efficacy compared with standard care regimens over 240 weeks.
www.infectiousdiseaseadvisor.com
June 17, 2026 at 7:24 PM
From @ofidjournal.bsky.social 🦠
#Dolutegravir-based #AntiRetroviralTherapy demonstrates superior efficacy compared with standard care regimens over 240 weeks among pediatric patients with #HIV, reinforcing current WHO guidelines.
#Dolutegravir-based #AntiRetroviralTherapy demonstrates superior efficacy compared with standard care regimens over 240 weeks among pediatric patients with #HIV, reinforcing current WHO guidelines.
Long-acting HIV prevention strategies are transforming global health. Research exploring the lenacapavir era highlights advances in therapeutic prevention and expanded protection for key populations
doi.org/10.1016/j.dc...
#HIVPrevention #Lenacapavir #AntiretroviralTherapy #GlobalHealth #HIVResearch
doi.org/10.1016/j.dc...
#HIVPrevention #Lenacapavir #AntiretroviralTherapy #GlobalHealth #HIVResearch
April 14, 2026 at 8:42 PM
Long-acting HIV prevention strategies are transforming global health. Research exploring the lenacapavir era highlights advances in therapeutic prevention and expanded protection for key populations
doi.org/10.1016/j.dc...
#HIVPrevention #Lenacapavir #AntiretroviralTherapy #GlobalHealth #HIVResearch
doi.org/10.1016/j.dc...
#HIVPrevention #Lenacapavir #AntiretroviralTherapy #GlobalHealth #HIVResearch
Viraday Tablet for HIV Treatment: B2B Supply, Uses, and in the UK - Oddway
www.oddwayinternational.com/viraday-tabl...
#ViradayTablet #HIVTreatment #AntiretroviralTherapy #MedicineExport
The viraday tablet serves as an essential antiretroviral.
www.oddwayinternational.com/viraday-tabl...
#ViradayTablet #HIVTreatment #AntiretroviralTherapy #MedicineExport
The viraday tablet serves as an essential antiretroviral.
April 3, 2026 at 8:38 AM
Viraday Tablet for HIV Treatment: B2B Supply, Uses, and in the UK - Oddway
www.oddwayinternational.com/viraday-tabl...
#ViradayTablet #HIVTreatment #AntiretroviralTherapy #MedicineExport
The viraday tablet serves as an essential antiretroviral.
www.oddwayinternational.com/viraday-tabl...
#ViradayTablet #HIVTreatment #AntiretroviralTherapy #MedicineExport
The viraday tablet serves as an essential antiretroviral.
🚨 NEW RESEARCH! ⚕️ 🩺
Fernandez et al. assess Dolutegravir use and HTLV-1 proviral load in HIV-HTLV-1 coinfected patients.
http://dlvr.it/TRJkWj #AntiretroviralTherapy #HTLV1
Fernandez et al. assess Dolutegravir use and HTLV-1 proviral load in HIV-HTLV-1 coinfected patients.
http://dlvr.it/TRJkWj #AntiretroviralTherapy #HTLV1
Dolutegravir use is related to lower HTLV-1 proviral load in people co-infected by HIV-1 - Communications Medicine
Fernandez et al. compare the HTLV-1 proviral load in people with HIV-1-HTLV-1 coinfection on stable antiretroviral therapy or people with HTLV-1 single infection without antiretroviral therapy. Dolutegravir use for longer than six months is associated with lower HTLV-1 proviral load.
dlvr.it
March 5, 2026 at 12:37 PM
🚨 NEW RESEARCH! ⚕️ 🩺
Fernandez et al. assess Dolutegravir use and HTLV-1 proviral load in HIV-HTLV-1 coinfected patients.
http://dlvr.it/TRJkWj #AntiretroviralTherapy #HTLV1
Fernandez et al. assess Dolutegravir use and HTLV-1 proviral load in HIV-HTLV-1 coinfected patients.
http://dlvr.it/TRJkWj #AntiretroviralTherapy #HTLV1
#ViiV #Pfizer #ViiVHealthcare #Shionogi #HIV #GSK #strategicpartnership #jointventure #HIVtherapies #GileadSciences #HIVtreatment #antiretroviraltherapy #longeractinginjectableregimens #HIVpreexposureprophylaxis #PrEP #preexposureprophylaxis #Apretude #cabotegravir #lenacapavir
zurl.co/khJ6D
zurl.co/khJ6D
ViiV ownership shifts as Pfizer sells its stake
Pfizer will relinquish its stake in HIV firm ViiV in a deal valued at $2.1bn that ramps up Shionogi's interest and simplifies its share structure
pharmaphorum.com
January 27, 2026 at 11:46 AM
Federally Funded Clinical Trial Suggests Knowing HIV ‘Viral Load’ Doesn’t Improve Number of Patients Seeking Needed Care
www.newswise.com/articles/fed...
#antiretroviraltherapy #HIV #JohnsHopkinsMedicine #PreExposureProphylaxis #viralloadtesting #matthewhamill #linkagetocare #yukamanabe
www.newswise.com/articles/fed...
#antiretroviraltherapy #HIV #JohnsHopkinsMedicine #PreExposureProphylaxis #viralloadtesting #matthewhamill #linkagetocare #yukamanabe
Federally Funded Clinical Trial Suggests Knowing HIV ‘Viral Load’ Doesn’t Improve Number of Patients Seeking Needed Care | Newswise
According to the U.S. Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million people living with HIV in the United States, and another 1.2 to 2.2 millio...
www.newswise.com
December 17, 2025 at 5:05 AM
Federally Funded Clinical Trial Suggests Knowing HIV ‘Viral Load’ Doesn’t Improve Number of Patients Seeking Needed Care
www.newswise.com/articles/fed...
#antiretroviraltherapy #HIV #JohnsHopkinsMedicine #PreExposureProphylaxis #viralloadtesting #matthewhamill #linkagetocare #yukamanabe
www.newswise.com/articles/fed...
#antiretroviraltherapy #HIV #JohnsHopkinsMedicine #PreExposureProphylaxis #viralloadtesting #matthewhamill #linkagetocare #yukamanabe
Merck’s two-drug regimen DOR/ISL shows non-inferiority to BIC/FTC/TAF in treatment-naïve adults with HIV-1.
🔗 Full article: stellanews.life/technology_c...
#Merck #MSD #HIV #DORISL #HIVTreatment #ClinicalTrial #AntiretroviralTherapy #Biopharma #MedicalNews
🔗 Full article: stellanews.life/technology_c...
#Merck #MSD #HIV #DORISL #HIVTreatment #ClinicalTrial #AntiretroviralTherapy #Biopharma #MedicalNews
メルクのDOR/ISL、HIV初回治療で非劣性 第3相で良好な有効性と安全性を示す | STELLANEWS.LIFE
ドラビリン／イスラトラビル（DOR/ISL）の第3相試験で、HIV-1感染の治療未経験成人において非劣性を示した。BIC/FTC/TAFとの比較で、有効性・安全性ともに良好で、2剤併用療法の新たな選択肢として注目される。
stellanews.life
November 24, 2025 at 9:49 PM
Merck’s two-drug regimen DOR/ISL shows non-inferiority to BIC/FTC/TAF in treatment-naïve adults with HIV-1.
🔗 Full article: stellanews.life/technology_c...
#Merck #MSD #HIV #DORISL #HIVTreatment #ClinicalTrial #AntiretroviralTherapy #Biopharma #MedicalNews
🔗 Full article: stellanews.life/technology_c...
#Merck #MSD #HIV #DORISL #HIVTreatment #ClinicalTrial #AntiretroviralTherapy #Biopharma #MedicalNews
[Publication] The article "Real-life evaluation of intermittent triple antiretroviral therapy maintenance strategies" is now available.
www.sciencedirect.com/science/arti...
#IDsky #HIV #AntiretroviralTherapy #IntermittentTripleHIVTreatment
www.sciencedirect.com/science/arti...
#IDsky #HIV #AntiretroviralTherapy #IntermittentTripleHIVTreatment
Real-life evaluation of intermittent triple antiretroviral therapy maintenance strategies
Intermittent antiretroviral therapy (ART) is commonly prescribed in France, but this strategy is not recommended internationally. The objective of thi…
www.sciencedirect.com
October 6, 2025 at 6:58 AM
[Publication] The article "Real-life evaluation of intermittent triple antiretroviral therapy maintenance strategies" is now available.
www.sciencedirect.com/science/arti...
#IDsky #HIV #AntiretroviralTherapy #IntermittentTripleHIVTreatment
www.sciencedirect.com/science/arti...
#IDsky #HIV #AntiretroviralTherapy #IntermittentTripleHIVTreatment
#DouglasCoupland #LifeAfterGod #LiteratureAndScience #HIV #Retrovirus #SingaporeSling #MedicalHistory #NobelPrize #AntiretroviralTherapy #AIDS #BookTrivia #digitalart #py5
September 16, 2025 at 8:38 AM
newsspacezim.co.zw/2025/09/02/l... #HIV #Zimbabwe #NationalAidsCouncil #paediatric #health #ART #antiretroviraltherapy
Low ART coverage for children in Midlands Province - newsspace
NAC Manager for Midlands Province, Mambewu Shumba addresses the media BY MUNYARADZI BLESSING DOMA in KWEKWE Whilst the country has achieved the 95-95-95 UNAIDS targets to end AIDS by 2030, Midlands Pr...
newsspacezim.co.zw
September 4, 2025 at 5:45 PM
Read about how uncontrolled #HIV viremia results in the progression to #AIDS, and how this can be stopped with #AntiretroviralTherapy (#ART) in the latest Journal of #Infection 👉 www.journalofinfecti...
August 13, 2025 at 9:09 AM
Read about how uncontrolled #HIV viremia results in the progression to #AIDS, and how this can be stopped with #AntiretroviralTherapy (#ART) in the latest Journal of #Infection 👉 www.journalofinfecti...
❗OUT NOW! In a translational research collaboration between @bqbiomedmolub.bsky.social & @irsantpau.bsky.social we identify ⬇️circulating #CXCL14 as a subclinical cardiovascular disease biomarker in people living with #HIV on #antiretroviraltherapy💊🫀
Open access here ➡️ doi.org/10.1016/j.ej...
Open access here ➡️ doi.org/10.1016/j.ej...
July 28, 2025 at 4:03 PM
❗OUT NOW! In a translational research collaboration between @bqbiomedmolub.bsky.social & @irsantpau.bsky.social we identify ⬇️circulating #CXCL14 as a subclinical cardiovascular disease biomarker in people living with #HIV on #antiretroviraltherapy💊🫀
Open access here ➡️ doi.org/10.1016/j.ej...
Open access here ➡️ doi.org/10.1016/j.ej...